TERN240920P5000
- 0.50
- -0.35-41.18%
Terns Pharmaceuticals Newsroom
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $15
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $19
Jefferies Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $22
Jefferies Sticks to Their Buy Rating for Terns Pharmaceuticals (TERN)
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Announces Target Price $10
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $15
Buy Rating for Terns Pharmaceuticals Amid Forthcoming Milestones and Financial Stability
Terns Pharma Analyst Ratings
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $19
Buy Rating Affirmed on Terns Pharmaceuticals Ahead of Key Clinical Data Releases and Strong Financial Standing
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Terns Pharmaceuticals (TERN) and Stryker (SYK)
Mizuho Securities Keeps Their Buy Rating on Terns Pharmaceuticals (TERN)
Buy Rating Upheld for Terns Pharmaceuticals Amid Strong Prospects for TERN-701 and Financial Stability
Optimistic Buy Rating for Terns Pharmaceuticals Amid Promising Clinical Progress and Solid Financial Footing
Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)
Buy Rating Affirmed for Terns Pharmaceuticals Amid Robust Financials and Promising Pipeline Prospects
Terns Pharma Analyst Ratings
Hold Rating on Terns Pharmaceuticals Pending Clinical Trial Outcomes
Analysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Terns Pharmaceuticals (TERN)